Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Price:
1.2
USD
-1.64%
Market Cap:
9.5m
USD
Section:
Dividends
Shareholder Yield
Current shareholder yield for BCLI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
BCLI Price
Brainstorm Cell Therapeutics Inc
Brainstorm Cell Therapeutics Inc
Annual Price Range
1.2
52w Low
0.7624
52w High
6.3
Price Metrics
| Average Annual Return | -51.32% |
| Standard Deviation of Annual Returns | 31.56% |
| Max Drawdown | -100% |
Shares Statistics
| Market Capitalization | 9.5m USD |
| Shares Outstanding | 7 940 000 |
| Percentage of Shares Shorted | 7.48% |
Stock Splits
BCLI's latest stock split occurred on Oct 1, 2024
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, BCLI traded at 0.2303 per share. Afterward, the share price was about 3.25.
The adjusted shares began trading on Oct 1, 2024. This was BCLI's 3rd stock split, following the previous one in Sep 16, 2014.
Pre-Split Price
0.2303
Post-Split Price
3.25
Before
After
You don't have any saved screeners yet
